Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added navigation and information sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status update indicating no longer recruiting. The page also standardizes the label 'Intervention/Treatment' and updates the revision version reference.
    Difference
    0.2%
    Check dated 2026-06-12T16:45:19.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing v3.5.4, indicating a newer build. This is a routine maintenance update and does not affect the clinical trial details or how the page is used.
    Difference
    0.0%
    Check dated 2026-06-05T16:13:50.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, signaling a version bump for the page. This appears to be a minor, metadata-level update rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-05-15T05:51:51.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s location text for the Chile site has been updated to use a shorter “Valparaiso” label instead of “Región de Valparaíso.” The displayed site revision/version string was also bumped from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Updated the collaborator name from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and revised the page version from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:13.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added a citation: Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma (N Engl J Med, 2021). Deleted the Erratum entry for that publication.
    Difference
    0.0%
    Check dated 2026-04-02T15:34:12.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.